Relation of serum resistin to subclinical atherosclerosis in multiple sclerosis

Table 2 Comparison of demographic characteristics, laboratory findings, and carotid intimal medial thickness in MS sufferers respect to clinical subtypes

Variables	RRMS (n = 86)	SPMS (n = 20)	PPMS (n = 8)
Age	37.33 ± 7.41	35.22 ± 6.42	36.63 ± 9.15
Gender
Male	27 (31%)	7 (35%)	2 (25%)
Female	59 (69%)	13 (65%)	6 (75%)
Smoking	21 (24%)	4 (20%)	2 (25%)
Age of MS onset (years)	27.39 ± 6.79	27.39 ± 6.79	27.39 ± 6.79
Body mass index(kg/m2)	27.68 ± 6.93	25.18 ± 5.03	25.34 ± 6.19
Total cholesterol (mg/dl)	171.68 ± 2.13	186.45 ± 2.67 ^+*	182.45 ± 2.76 ^*
Triglycerides (mg/dl)	138.95 ± 16.52^*	108.18 ± 5.13	107.59 ± 5.45
HDL (mg/dl)	59.57 ± 6.4	60.51 ± 5.9	60.49 ± 5.8
LDL (mg/dl)	109.32 ± 3.35	112.32 ± 3.53	113.23 ± 3.55
Resistin (ng/mL)	14.29 ± 4.66	14.16 ± 4.19	15.39 ± 4.12
Mean CIMT (mm)	0.57 ± 0.13	0.56 ± 0.12	0.56 ± 0.11
Right CIMT (mm)	0.59 ± 0.09	0.58 ± 0.19	0.57 ± 0.08
Left CIMT (mm)	0.53 ± 0.11	0.53 ± 0.9	0.54 ± 0.11

RRMS relapsing–remitting multiple sclerosis, SPMS secondary progressive multiple sclerosis, PPMS primary progressive multiple sclerosis, n number, % percentages, HDL high-density lipoprotein; LDL: low-density lipoprotein; CIMT: carotid intimal medial thickness
*Significant comparing either RRMS versus PPMS or SPMS, + significant comparing SPMS versus PPMS